| Name | Antazoline hydrochloride |
| Description | Antazoline hydrochloride (Phenazoline hydrochloride), a first-generation antihistamine, can bind to the histamine H1 receptor and block the action of endogenous histamine. |
| In vitro | In the model of sustained epileptic state induced by picrotoxin, Antazoline can be utilized to protect the intrinsic neural circuitry. |
| In vivo | At a concentration of 30 μM, Antazoline effectively reduces neurotoxicity mediated by NMDA and also blocks NMDA-induced currents via a voltage-dependent and rapidly reversible action, with an inhibition rate of 85±3% at a voltage of -60 mV. |
| Storage | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 45 mg/mL (149.1 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween-80+45% Saline : 2 mg/mL (6.63 mM), Sonication is recommended. H2O : 14 mg/mL (46.39 mM), Sonication is recommended. Ethanol : 4 mg/mL (13.25 mM), Sonication is recommended.
|
| Keywords | Phenazoline Hydrochloride | Phenazoline | Inhibitor | inhibit | HistamineReceptor | Histamine Receptor | H1 receptor | Antazoline hydrochloride | Antazoline |
| Inhibitors Related | Undecane | Meclizine dihydrochloride | Lamivudine | Famotidine | Cetylpyridinium Chloride | Tenofovir Disoproxil Fumarate | Sodium butanoate | Thiamine hydrochloride | Alginic acid | Mianserin hydrochloride | Nicotinamide | Tenofovir |
| Related Compound Libraries | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Drug Repurposing Compound Library | Anti-Viral Compound Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Immunology/Inflammation Compound Library | Bitter Compound library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |